The promise of molecular targeted therapies: Protein kinase inhibitors in the treatment of cutaneous malignancies

This publication has 69 references indexed in Scilit:

• Opportunities and challenges in the development of kinase inhibitor therapy for cancer
  Genes & Development, 2003
• Issues and progress with protein kinase inhibitors for cancer treatment
  Nature Reviews Drug Discovery, 2003
• A decade of tyrosine kinases: from gene discovery to therapeutics
  Surgical Oncology, 2003
• The Protein Kinase Complement of the Human Genome
  Science, 2002
• Oncogenic kinase signalling
  Nature, 2001
• Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia
  New England Journal of Medicine, 2001
• Protein tyrosine kinases in malignant melanoma
  Melanoma Research, 2000
• Kinase Inhibitors in Cancer Therapy
  Drugs, 2000
• The Hallmarks of Cancer
  Cell, 2000
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining
  Nature, 1973